De Novo
DEN180008: MolecuLight i:X
FDA De Novo · moleculight inc. · decided Jul 31, 2018
Key facts
| De Novo number | DEN180008 |
|---|---|
| Device name | MolecuLight i:X |
| Applicant | moleculight inc. |
| Product code | QCR |
| Date received | Feb 16, 2018 |
| Decision date | Jul 31, 2018 |
| Decision | granted (DENG) |
| FDA classification | Class I |
| Review panel | General & Plastic Surgery |
| FEI number | 3014704068 |
At a glance
- 1–9 Later 510(k)s citing this De Novo
- 1–9 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: